nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Pain in jaw—Vinorelbine—ovarian cancer	0.0308	0.0455	CcSEcCtD
Phentolamine—Oral pain—Paclitaxel—ovarian cancer	0.0259	0.0382	CcSEcCtD
Phentolamine—Hypotensive—Paclitaxel—ovarian cancer	0.0185	0.0273	CcSEcCtD
Phentolamine—NISCH—Paclitaxel—Docetaxel—ovarian cancer	0.0184	0.446	CbGdCrCtD
Phentolamine—Oral pain—Epirubicin—ovarian cancer	0.0148	0.0218	CcSEcCtD
Phentolamine—NISCH—uterine cervix—ovarian cancer	0.0146	0.0521	CbGeAlD
Phentolamine—Swelling face—Paclitaxel—ovarian cancer	0.0142	0.0209	CcSEcCtD
Phentolamine—NISCH—decidua—ovarian cancer	0.0139	0.0496	CbGeAlD
Phentolamine—Oral pain—Doxorubicin—ovarian cancer	0.0137	0.0202	CcSEcCtD
Phentolamine—NISCH—Vincristine—Vinorelbine—ovarian cancer	0.0127	0.307	CbGdCrCtD
Phentolamine—ADRA1D—epithelium—ovarian cancer	0.0123	0.0439	CbGeAlD
Phentolamine—Injection site pain—Vinorelbine—ovarian cancer	0.0123	0.0182	CcSEcCtD
Phentolamine—NISCH—uterus—ovarian cancer	0.0122	0.0434	CbGeAlD
Phentolamine—Injection site reaction—Melphalan—ovarian cancer	0.0114	0.0169	CcSEcCtD
Phentolamine—SIGMAR1—myometrium—ovarian cancer	0.0109	0.039	CbGeAlD
Phentolamine—NISCH—bone marrow—ovarian cancer	0.0104	0.0369	CbGeAlD
Phentolamine—NISCH—Vinblastine—Vinorelbine—ovarian cancer	0.0102	0.247	CbGdCrCtD
Phentolamine—Injection site reaction—Vinorelbine—ovarian cancer	0.00999	0.0147	CcSEcCtD
Phentolamine—NISCH—female gonad—ovarian cancer	0.00998	0.0355	CbGeAlD
Phentolamine—NISCH—vagina—ovarian cancer	0.00992	0.0353	CbGeAlD
Phentolamine—Asthenia—Altretamine—ovarian cancer	0.0095	0.014	CcSEcCtD
Phentolamine—ADRA1D—female reproductive system—ovarian cancer	0.00915	0.0326	CbGeAlD
Phentolamine—NISCH—testis—ovarian cancer	0.00885	0.0315	CbGeAlD
Phentolamine—Dizziness—Altretamine—ovarian cancer	0.00876	0.0129	CcSEcCtD
Phentolamine—ADRA2C—myometrium—ovarian cancer	0.00859	0.0306	CbGeAlD
Phentolamine—SIGMAR1—uterine cervix—ovarian cancer	0.00851	0.0303	CbGeAlD
Phentolamine—Vomiting—Altretamine—ovarian cancer	0.00842	0.0124	CcSEcCtD
Phentolamine—SIGMAR1—decidua—ovarian cancer	0.00811	0.0289	CbGeAlD
Phentolamine—Nausea—Altretamine—ovarian cancer	0.00787	0.0116	CcSEcCtD
Phentolamine—Pain—Carboplatin—ovarian cancer	0.00783	0.0115	CcSEcCtD
Phentolamine—Tenderness—Paclitaxel—ovarian cancer	0.00775	0.0114	CcSEcCtD
Phentolamine—SIGMAR1—endometrium—ovarian cancer	0.0077	0.0274	CbGeAlD
Phentolamine—SIGMAR1—uterus—ovarian cancer	0.0071	0.0253	CbGeAlD
Phentolamine—ADRA1A—epithelium—ovarian cancer	0.00708	0.0252	CbGeAlD
Phentolamine—ADRA2A—myometrium—ovarian cancer	0.00686	0.0244	CbGeAlD
Phentolamine—Blood pressure increased—Paclitaxel—ovarian cancer	0.00676	0.00997	CcSEcCtD
Phentolamine—Injection site reaction—Paclitaxel—ovarian cancer	0.00672	0.00991	CcSEcCtD
Phentolamine—ADRA2C—uterine cervix—ovarian cancer	0.00669	0.0238	CbGeAlD
Phentolamine—NISCH—lymph node—ovarian cancer	0.00642	0.0228	CbGeAlD
Phentolamine—ADRA2C—decidua—ovarian cancer	0.00637	0.0227	CbGeAlD
Phentolamine—Angina pectoris—Vinorelbine—ovarian cancer	0.00614	0.00906	CcSEcCtD
Phentolamine—ADRA2C—endometrium—ovarian cancer	0.00605	0.0215	CbGeAlD
Phentolamine—SIGMAR1—bone marrow—ovarian cancer	0.00602	0.0214	CbGeAlD
Phentolamine—SIGMAR1—female gonad—ovarian cancer	0.0058	0.0207	CbGeAlD
Phentolamine—SIGMAR1—vagina—ovarian cancer	0.00577	0.0205	CbGeAlD
Phentolamine—Blood pressure increased—Docetaxel—ovarian cancer	0.00573	0.00845	CcSEcCtD
Phentolamine—Injection site reaction—Docetaxel—ovarian cancer	0.0057	0.0084	CcSEcCtD
Phentolamine—ADRA2C—uterus—ovarian cancer	0.00557	0.0198	CbGeAlD
Phentolamine—Acute coronary syndrome—Vinorelbine—ovarian cancer	0.00554	0.00818	CcSEcCtD
Phentolamine—Myocardial infarction—Vinorelbine—ovarian cancer	0.00551	0.00813	CcSEcCtD
Phentolamine—Nasal congestion—Paclitaxel—ovarian cancer	0.00539	0.00795	CcSEcCtD
Phentolamine—Flushing—Melphalan—ovarian cancer	0.00536	0.00791	CcSEcCtD
Phentolamine—Angiopathy—Topotecan—ovarian cancer	0.00535	0.0079	CcSEcCtD
Phentolamine—ADRA2A—uterine cervix—ovarian cancer	0.00534	0.019	CbGeAlD
Phentolamine—Mediastinal disorder—Topotecan—ovarian cancer	0.00532	0.00784	CcSEcCtD
Phentolamine—Mediastinal disorder—Melphalan—ovarian cancer	0.00521	0.00768	CcSEcCtD
Phentolamine—Arrhythmia—Melphalan—ovarian cancer	0.00516	0.00761	CcSEcCtD
Phentolamine—SIGMAR1—testis—ovarian cancer	0.00515	0.0183	CbGeAlD
Phentolamine—ADRA2A—decidua—ovarian cancer	0.00508	0.0181	CbGeAlD
Phentolamine—ADRA2A—endometrium—ovarian cancer	0.00483	0.0172	CbGeAlD
Phentolamine—Injection site pain—Epirubicin—ovarian cancer	0.00473	0.00698	CcSEcCtD
Phentolamine—Cardiac disorder—Vinorelbine—ovarian cancer	0.00468	0.00691	CcSEcCtD
Phentolamine—Flushing—Vinorelbine—ovarian cancer	0.00468	0.00691	CcSEcCtD
Phentolamine—Angiopathy—Vinorelbine—ovarian cancer	0.00458	0.00675	CcSEcCtD
Phentolamine—ADRA2C—female gonad—ovarian cancer	0.00456	0.0162	CbGeAlD
Phentolamine—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00455	0.00671	CcSEcCtD
Phentolamine—ADRA2C—vagina—ovarian cancer	0.00453	0.0161	CbGeAlD
Phentolamine—Arrhythmia—Vinorelbine—ovarian cancer	0.00451	0.00665	CcSEcCtD
Phentolamine—Orthostatic hypotension—Paclitaxel—ovarian cancer	0.00448	0.00661	CcSEcCtD
Phentolamine—Abdominal pain upper—Paclitaxel—ovarian cancer	0.00448	0.00661	CcSEcCtD
Phentolamine—ADRA2A—gonad—ovarian cancer	0.00448	0.0159	CbGeAlD
Phentolamine—ADRA2A—uterus—ovarian cancer	0.00445	0.0158	CbGeAlD
Phentolamine—Injection site pain—Doxorubicin—ovarian cancer	0.00438	0.00646	CcSEcCtD
Phentolamine—Chest pain—Topotecan—ovarian cancer	0.00437	0.00645	CcSEcCtD
Phentolamine—Chest pain—Melphalan—ovarian cancer	0.00428	0.00632	CcSEcCtD
Phentolamine—Nervous system disorder—Topotecan—ovarian cancer	0.00411	0.00606	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00406	0.006	CcSEcCtD
Phentolamine—ADRA2C—testis—ovarian cancer	0.00404	0.0144	CbGeAlD
Phentolamine—Pain—Chlorambucil—ovarian cancer	0.00403	0.00594	CcSEcCtD
Phentolamine—Tachycardia—Melphalan—ovarian cancer	0.00401	0.00591	CcSEcCtD
Phentolamine—ADRA2A—female reproductive system—ovarian cancer	0.004	0.0142	CbGeAlD
Phentolamine—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.00385	0.00568	CcSEcCtD
Phentolamine—Injection site reaction—Epirubicin—ovarian cancer	0.00384	0.00567	CcSEcCtD
Phentolamine—Hypotension—Melphalan—ovarian cancer	0.00383	0.00566	CcSEcCtD
Phentolamine—Abdominal pain upper—Docetaxel—ovarian cancer	0.0038	0.0056	CcSEcCtD
Phentolamine—Orthostatic hypotension—Docetaxel—ovarian cancer	0.0038	0.0056	CcSEcCtD
Phentolamine—Hypertension—Vinorelbine—ovarian cancer	0.00379	0.0056	CcSEcCtD
Phentolamine—Paraesthesia—Topotecan—ovarian cancer	0.00376	0.00555	CcSEcCtD
Phentolamine—Chest pain—Vinorelbine—ovarian cancer	0.00374	0.00552	CcSEcCtD
Phentolamine—SIGMAR1—lymph node—ovarian cancer	0.00373	0.0133	CbGeAlD
Phentolamine—Acute coronary syndrome—Paclitaxel—ovarian cancer	0.00373	0.0055	CcSEcCtD
Phentolamine—Abdominal pain—Chlorambucil—ovarian cancer	0.00372	0.00549	CcSEcCtD
Phentolamine—Myocardial infarction—Paclitaxel—ovarian cancer	0.00371	0.00547	CcSEcCtD
Phentolamine—Paraesthesia—Melphalan—ovarian cancer	0.00369	0.00544	CcSEcCtD
Phentolamine—ADRA2A—female gonad—ovarian cancer	0.00364	0.0129	CbGeAlD
Phentolamine—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00362	0.00534	CcSEcCtD
Phentolamine—ADRA2A—vagina—ovarian cancer	0.00362	0.0129	CbGeAlD
Phentolamine—Pain—Topotecan—ovarian cancer	0.00358	0.00529	CcSEcCtD
Phentolamine—Injection site reaction—Doxorubicin—ovarian cancer	0.00355	0.00524	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00354	0.00523	CcSEcCtD
Phentolamine—Nervous system disorder—Vinorelbine—ovarian cancer	0.00352	0.00519	CcSEcCtD
Phentolamine—Pain—Melphalan—ovarian cancer	0.00351	0.00518	CcSEcCtD
Phentolamine—Angina pectoris—Docetaxel—ovarian cancer	0.0035	0.00517	CcSEcCtD
Phentolamine—Tachycardia—Vinorelbine—ovarian cancer	0.0035	0.00516	CcSEcCtD
Phentolamine—Bradycardia—Paclitaxel—ovarian cancer	0.00346	0.0051	CcSEcCtD
Phentolamine—Gastrointestinal pain—Topotecan—ovarian cancer	0.00343	0.00506	CcSEcCtD
Phentolamine—Asthenia—Chlorambucil—ovarian cancer	0.00338	0.00498	CcSEcCtD
Phentolamine—Hypotension—Vinorelbine—ovarian cancer	0.00335	0.00494	CcSEcCtD
Phentolamine—Pruritus—Chlorambucil—ovarian cancer	0.00333	0.00491	CcSEcCtD
Phentolamine—Abdominal pain—Topotecan—ovarian cancer	0.00331	0.00489	CcSEcCtD
Phentolamine—ADRA2A—testis—ovarian cancer	0.00323	0.0115	CbGeAlD
Phentolamine—Diarrhoea—Chlorambucil—ovarian cancer	0.00322	0.00475	CcSEcCtD
Phentolamine—Paraesthesia—Vinorelbine—ovarian cancer	0.00322	0.00475	CcSEcCtD
Phentolamine—Acute coronary syndrome—Docetaxel—ovarian cancer	0.00316	0.00466	CcSEcCtD
Phentolamine—Flushing—Paclitaxel—ovarian cancer	0.00315	0.00465	CcSEcCtD
Phentolamine—Cardiac disorder—Paclitaxel—ovarian cancer	0.00315	0.00465	CcSEcCtD
Phentolamine—Myocardial infarction—Docetaxel—ovarian cancer	0.00314	0.00463	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.0031	0.00457	CcSEcCtD
Phentolamine—Angiopathy—Paclitaxel—ovarian cancer	0.00308	0.00454	CcSEcCtD
Phentolamine—Pain—Vinorelbine—ovarian cancer	0.00307	0.00452	CcSEcCtD
Phentolamine—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00306	0.00451	CcSEcCtD
Phentolamine—Arrhythmia—Paclitaxel—ovarian cancer	0.00303	0.00447	CcSEcCtD
Phentolamine—Asthenia—Topotecan—ovarian cancer	0.00301	0.00444	CcSEcCtD
Phentolamine—Vomiting—Chlorambucil—ovarian cancer	0.00299	0.00442	CcSEcCtD
Phentolamine—Pruritus—Topotecan—ovarian cancer	0.00297	0.00437	CcSEcCtD
Phentolamine—Asthenia—Melphalan—ovarian cancer	0.00294	0.00434	CcSEcCtD
Phentolamine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00293	0.00433	CcSEcCtD
Phentolamine—ADRA2C—lymph node—ovarian cancer	0.00293	0.0104	CbGeAlD
Phentolamine—Pruritus—Melphalan—ovarian cancer	0.0029	0.00428	CcSEcCtD
Phentolamine—Diarrhoea—Topotecan—ovarian cancer	0.00287	0.00423	CcSEcCtD
Phentolamine—Abdominal pain—Vinorelbine—ovarian cancer	0.00283	0.00418	CcSEcCtD
Phentolamine—Diarrhoea—Melphalan—ovarian cancer	0.00281	0.00414	CcSEcCtD
Phentolamine—Nausea—Chlorambucil—ovarian cancer	0.0028	0.00413	CcSEcCtD
Phentolamine—Dizziness—Topotecan—ovarian cancer	0.00277	0.00409	CcSEcCtD
Phentolamine—Flushing—Docetaxel—ovarian cancer	0.00267	0.00394	CcSEcCtD
Phentolamine—Cardiac disorder—Docetaxel—ovarian cancer	0.00267	0.00394	CcSEcCtD
Phentolamine—Vomiting—Topotecan—ovarian cancer	0.00266	0.00393	CcSEcCtD
Phentolamine—Headache—Topotecan—ovarian cancer	0.00263	0.00387	CcSEcCtD
Phentolamine—Angiopathy—Docetaxel—ovarian cancer	0.00261	0.00385	CcSEcCtD
Phentolamine—Vomiting—Melphalan—ovarian cancer	0.00261	0.00385	CcSEcCtD
Phentolamine—Mediastinal disorder—Docetaxel—ovarian cancer	0.00259	0.00383	CcSEcCtD
Phentolamine—Asthenia—Vinorelbine—ovarian cancer	0.00257	0.00379	CcSEcCtD
Phentolamine—Arrhythmia—Docetaxel—ovarian cancer	0.00257	0.00379	CcSEcCtD
Phentolamine—Abdominal pain upper—Epirubicin—ovarian cancer	0.00256	0.00378	CcSEcCtD
Phentolamine—Orthostatic hypotension—Epirubicin—ovarian cancer	0.00256	0.00378	CcSEcCtD
Phentolamine—Hypertension—Paclitaxel—ovarian cancer	0.00255	0.00376	CcSEcCtD
Phentolamine—Pruritus—Vinorelbine—ovarian cancer	0.00254	0.00374	CcSEcCtD
Phentolamine—Chest pain—Paclitaxel—ovarian cancer	0.00252	0.00371	CcSEcCtD
Phentolamine—Nausea—Topotecan—ovarian cancer	0.00249	0.00367	CcSEcCtD
Phentolamine—Diarrhoea—Vinorelbine—ovarian cancer	0.00245	0.00362	CcSEcCtD
Phentolamine—Nausea—Melphalan—ovarian cancer	0.00244	0.0036	CcSEcCtD
Phentolamine—Dizziness—Vinorelbine—ovarian cancer	0.00237	0.0035	CcSEcCtD
Phentolamine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00237	0.0035	CcSEcCtD
Phentolamine—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.00237	0.0035	CcSEcCtD
Phentolamine—Nervous system disorder—Paclitaxel—ovarian cancer	0.00237	0.00349	CcSEcCtD
Phentolamine—Angina pectoris—Epirubicin—ovarian cancer	0.00236	0.00348	CcSEcCtD
Phentolamine—Tachycardia—Paclitaxel—ovarian cancer	0.00235	0.00347	CcSEcCtD
Phentolamine—ADRA2A—lymph node—ovarian cancer	0.00234	0.00832	CbGeAlD
Phentolamine—Vomiting—Vinorelbine—ovarian cancer	0.00228	0.00336	CcSEcCtD
Phentolamine—Hypotension—Paclitaxel—ovarian cancer	0.00225	0.00332	CcSEcCtD
Phentolamine—Headache—Vinorelbine—ovarian cancer	0.00225	0.00331	CcSEcCtD
Phentolamine—Angina pectoris—Doxorubicin—ovarian cancer	0.00219	0.00322	CcSEcCtD
Phentolamine—Paraesthesia—Paclitaxel—ovarian cancer	0.00217	0.00319	CcSEcCtD
Phentolamine—Hypertension—Docetaxel—ovarian cancer	0.00216	0.00319	CcSEcCtD
Phentolamine—Chest pain—Docetaxel—ovarian cancer	0.00213	0.00315	CcSEcCtD
Phentolamine—Nausea—Vinorelbine—ovarian cancer	0.00213	0.00314	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00208	0.00307	CcSEcCtD
Phentolamine—Pain—Paclitaxel—ovarian cancer	0.00206	0.00304	CcSEcCtD
Phentolamine—Nervous system disorder—Docetaxel—ovarian cancer	0.002	0.00296	CcSEcCtD
Phentolamine—Tachycardia—Docetaxel—ovarian cancer	0.002	0.00294	CcSEcCtD
Phentolamine—Bradycardia—Epirubicin—ovarian cancer	0.00198	0.00291	CcSEcCtD
Phentolamine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00197	0.00291	CcSEcCtD
Phentolamine—Hypotension—Docetaxel—ovarian cancer	0.00191	0.00282	CcSEcCtD
Phentolamine—Abdominal pain—Paclitaxel—ovarian cancer	0.00191	0.00281	CcSEcCtD
Phentolamine—Paraesthesia—Docetaxel—ovarian cancer	0.00184	0.00271	CcSEcCtD
Phentolamine—Bradycardia—Doxorubicin—ovarian cancer	0.00183	0.0027	CcSEcCtD
Phentolamine—Flushing—Epirubicin—ovarian cancer	0.0018	0.00266	CcSEcCtD
Phentolamine—Cardiac disorder—Epirubicin—ovarian cancer	0.0018	0.00266	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00176	0.0026	CcSEcCtD
Phentolamine—Angiopathy—Epirubicin—ovarian cancer	0.00176	0.0026	CcSEcCtD
Phentolamine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00175	0.00258	CcSEcCtD
Phentolamine—Pain—Docetaxel—ovarian cancer	0.00175	0.00258	CcSEcCtD
Phentolamine—Arrhythmia—Epirubicin—ovarian cancer	0.00173	0.00256	CcSEcCtD
Phentolamine—Asthenia—Paclitaxel—ovarian cancer	0.00173	0.00255	CcSEcCtD
Phentolamine—Pruritus—Paclitaxel—ovarian cancer	0.00171	0.00252	CcSEcCtD
Phentolamine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00167	0.00247	CcSEcCtD
Phentolamine—Flushing—Doxorubicin—ovarian cancer	0.00167	0.00246	CcSEcCtD
Phentolamine—Cardiac disorder—Doxorubicin—ovarian cancer	0.00167	0.00246	CcSEcCtD
Phentolamine—Diarrhoea—Paclitaxel—ovarian cancer	0.00165	0.00243	CcSEcCtD
Phentolamine—Angiopathy—Doxorubicin—ovarian cancer	0.00163	0.0024	CcSEcCtD
Phentolamine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00162	0.00239	CcSEcCtD
Phentolamine—Abdominal pain—Docetaxel—ovarian cancer	0.00162	0.00238	CcSEcCtD
Phentolamine—Arrhythmia—Doxorubicin—ovarian cancer	0.0016	0.00237	CcSEcCtD
Phentolamine—Dizziness—Paclitaxel—ovarian cancer	0.00159	0.00235	CcSEcCtD
Phentolamine—Vomiting—Paclitaxel—ovarian cancer	0.00153	0.00226	CcSEcCtD
Phentolamine—Headache—Paclitaxel—ovarian cancer	0.00151	0.00223	CcSEcCtD
Phentolamine—Asthenia—Docetaxel—ovarian cancer	0.00147	0.00216	CcSEcCtD
Phentolamine—Hypertension—Epirubicin—ovarian cancer	0.00146	0.00215	CcSEcCtD
Phentolamine—Pruritus—Docetaxel—ovarian cancer	0.00145	0.00213	CcSEcCtD
Phentolamine—Chest pain—Epirubicin—ovarian cancer	0.00144	0.00212	CcSEcCtD
Phentolamine—Nausea—Paclitaxel—ovarian cancer	0.00143	0.00211	CcSEcCtD
Phentolamine—Diarrhoea—Docetaxel—ovarian cancer	0.0014	0.00206	CcSEcCtD
Phentolamine—Nervous system disorder—Epirubicin—ovarian cancer	0.00135	0.00199	CcSEcCtD
Phentolamine—Dizziness—Docetaxel—ovarian cancer	0.00135	0.00199	CcSEcCtD
Phentolamine—Hypertension—Doxorubicin—ovarian cancer	0.00135	0.00199	CcSEcCtD
Phentolamine—Tachycardia—Epirubicin—ovarian cancer	0.00135	0.00199	CcSEcCtD
Phentolamine—Chest pain—Doxorubicin—ovarian cancer	0.00133	0.00196	CcSEcCtD
Phentolamine—Vomiting—Docetaxel—ovarian cancer	0.0013	0.00192	CcSEcCtD
Phentolamine—Hypotension—Epirubicin—ovarian cancer	0.00129	0.0019	CcSEcCtD
Phentolamine—Headache—Docetaxel—ovarian cancer	0.00128	0.00189	CcSEcCtD
Phentolamine—Nervous system disorder—Doxorubicin—ovarian cancer	0.00125	0.00185	CcSEcCtD
Phentolamine—Tachycardia—Doxorubicin—ovarian cancer	0.00125	0.00184	CcSEcCtD
Phentolamine—Paraesthesia—Epirubicin—ovarian cancer	0.00124	0.00183	CcSEcCtD
Phentolamine—Nausea—Docetaxel—ovarian cancer	0.00121	0.00179	CcSEcCtD
Phentolamine—Hypotension—Doxorubicin—ovarian cancer	0.00119	0.00176	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00119	0.00176	CcSEcCtD
Phentolamine—Pain—Epirubicin—ovarian cancer	0.00118	0.00174	CcSEcCtD
Phentolamine—Paraesthesia—Doxorubicin—ovarian cancer	0.00115	0.00169	CcSEcCtD
Phentolamine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00113	0.00166	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.0011	0.00162	CcSEcCtD
Phentolamine—Pain—Doxorubicin—ovarian cancer	0.00109	0.00161	CcSEcCtD
Phentolamine—Abdominal pain—Epirubicin—ovarian cancer	0.00109	0.00161	CcSEcCtD
Phentolamine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00104	0.00154	CcSEcCtD
Phentolamine—Abdominal pain—Doxorubicin—ovarian cancer	0.00101	0.00149	CcSEcCtD
Phentolamine—Asthenia—Epirubicin—ovarian cancer	0.000989	0.00146	CcSEcCtD
Phentolamine—Pruritus—Epirubicin—ovarian cancer	0.000975	0.00144	CcSEcCtD
Phentolamine—Diarrhoea—Epirubicin—ovarian cancer	0.000943	0.00139	CcSEcCtD
Phentolamine—Asthenia—Doxorubicin—ovarian cancer	0.000915	0.00135	CcSEcCtD
Phentolamine—Dizziness—Epirubicin—ovarian cancer	0.000912	0.00134	CcSEcCtD
Phentolamine—Pruritus—Doxorubicin—ovarian cancer	0.000903	0.00133	CcSEcCtD
Phentolamine—Vomiting—Epirubicin—ovarian cancer	0.000877	0.00129	CcSEcCtD
Phentolamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000873	0.00129	CcSEcCtD
Phentolamine—Headache—Epirubicin—ovarian cancer	0.000864	0.00127	CcSEcCtD
Phentolamine—Dizziness—Doxorubicin—ovarian cancer	0.000844	0.00124	CcSEcCtD
Phentolamine—Nausea—Epirubicin—ovarian cancer	0.000819	0.00121	CcSEcCtD
Phentolamine—Vomiting—Doxorubicin—ovarian cancer	0.000811	0.0012	CcSEcCtD
Phentolamine—Headache—Doxorubicin—ovarian cancer	0.000799	0.00118	CcSEcCtD
Phentolamine—Nausea—Doxorubicin—ovarian cancer	0.000758	0.00112	CcSEcCtD
